Evidence map›Paper›PMID 41500778›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2025

[Application of Explainable Deep Learning in Differentiating Benign from Malignant 
Pulmonary Space-occupying Lesions and Classifying Pathological Subtypes of Lung Cancer].

Haoran Li, Yuanyuan Wang, Yang Wang, Huihui He, Junya Li, Yanning Su, Fanrui Kong, Xiangli Liu, Liuhui Cheng, Ya Li

Abstract readEnglish Abstract
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Haoran LiFirst Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.
Yuanyuan WangNational Regional Diagnosis and Treatment Center for Traditional Chinese Medicine (Pulmonary Diseases), The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
Yang WangNational Regional Diagnosis and Treatment Center for Traditional Chinese Medicine (Pulmonary Diseases), The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
Huihui HeExperimental Center, The First Affiliated Hospital of Henan University of Chinese Medicine; Pharmacology of Chinese Materia Medica (Respiration) Laboratory; Henan Provincial Key Laboratory of Chinese Medicine for Respiratory Disease Prevention and Treatment, Zhengzhou 450000, China.
Junya LiFirst Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.
Yanning SuFirst Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.
Fanrui KongSecond Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.
Xiangli LiuDepartment of Pathology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
Liuhui ChengDepartment of Radiology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
Ya LiFirst Clinical Medical College, Henan University of Chinese Medicine, Zhengzhou 450000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe discrimination between benign and malignant pulmonary space-occupying lesions and the classification of pathological subtypes of lung cancer are critical for clinical decision-making. However, conventional methods often suffer from insufficient utilization of multi-source clinical data and poor interpretability of deep learning models. This study investigates the performance of interpretable deep learning algorithms in diagnosing benign versus malignant pulmonary space-occupying lesions and classifying pathological subtypes of lung cancer, using a hybrid architecture based on Tab-Transformer-designed for tabular data and Residual Multi-Layer Perceptron (ResMLP), referred to as TT-ResMLP.

methodsData including radiological characteristics, medical history, and laboratory findings from 345 patients with pathologically confirmed pulmonary space-occupying lesions were collected. The dataset was randomly split into a development set and a test set at an 8:2 ratio. Stable features were selected using the Spearman correlation test and the Least Absolute Shrinkage and Selection Operator (LASSO). The Synthetic Minority Over-sampling Technique (SMOTE) was employed to balance the samples, and 10-fold cross-validation was used to enhance model generalizability. Models were constructed using the Tab-Transformer algorithm, the ResMLP algorithm, and the TT-ResMLP hybrid. Model performance was evaluated using receiver operating characteristic (ROC) curves, the area under the curve (AUC), accuracy, specificity, sensitivity, and micro-averaged ROC (micro-ROC). SHapley Additive exPlanations (SHAP) analysis was performed based on the optimal model.

resultsIn the benign vs malignant diagnosis task, all three models performed well. The Tab-Transformer model demonstrated the best performance on the test set, followed by TT-ResMLP and ResMLP. SHAP analysis of the top-performing Tab-Transformer model revealed that the feature importance ranking was: age, pleural indentation, thrombin time, mean density, and ground-glass opacity. Pleural indentation contributed substantially to malignant diagnosis, and its contribution was further enhanced with increasing age and decreasing thrombin time. In the lung cancer subtype classification task, all three models exhibited excellent performance, with the TT-ResMLP hybrid showing the best overall performance. SHAP analysis further revealed that the Lung Imaging Reporting and Data System (Lung-RADS) category held high importance across all three pathological subtypes. Male gender was positively associated with the prediction of squamous cell carcinoma. Neuron-specific enolase (NSE) played a significant role in predicting small cell carcinoma. For adenocarcinoma, the diagnostic probability was positively correlated with the Lung-RADS category, a relationship more pronounced at lower prothrombin time (PT) values. In contrast, a negative correlation was observed in the squamous cell carcinoma and small cell carcinoma subgroups, although gender and NSE levels could enhance their contributory risk prediction. Analysis of feature decision boundaries indicated that the Lung-RADS grade possessed high discriminative power for identifying adenocarcinoma, whereas NSE demonstrated stronger discriminative ability for identifying small cell carcinoma.

conclusionsThe TT-ResMLP hybrid architecture is effective for diagnosing the benign or malignant nature of pulmonary space-occupying lesions and classifying pathological subtypes of lung cancer. The model possesses good interpretability, aiding in the identification of key predictive features and unravelling their interactive mechanisms, thereby providing an effective tool for a deeper understanding of lung cancer biology and clinical decision support.

Indexed as

Deep LearningLung NeoplasmsAgedClassification AlgorithmsDiagnosis, DifferentialFemaleHumansMaleMiddle AgedBenign-malignant diagnosisDeep learningFeature interpretationLung neoplasmsMachine learningPulmonary space-occupying lesion

Identifiers

PMID41500778
PMCPMC12782943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.